These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33989509)

  • 41. Evaluation of immunization injection safety in China, 2010: achievements, future sustainability.
    Wu Z; Cui F; Chen Y; Miao N; Gong X; Luo H; Wang F; Zheng H; Kane M; Hadler SC; Hutin YJ; Liang X; Yang W
    Vaccine; 2013 Dec; 31 Suppl 9():J43-8. PubMed ID: 24331020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India.
    Bahuguna P; Prinja S; Lahariya C; Dhiman RK; Kumar MP; Sharma V; Aggarwal AK; Bhaskar R; De Graeve H; Bekedam H
    Appl Health Econ Health Policy; 2020 Jun; 18(3):393-411. PubMed ID: 31741306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reuse of disposable syringe-needle units in the diabetic patient.
    Crouch M; Jones A; Kleinbeck E; Reece E; Bessman AN
    Diabetes Care; 1979; 2(5):418-20. PubMed ID: 510141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Injection risks and HIV transmission in the Republic of South Africa.
    Reid S; Van Niekerk AA
    Int J STD AIDS; 2009 Dec; 20(12):816-9. PubMed ID: 19948894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Injection practices in 2011-2015: a review using data from the demographic and health surveys (DHS).
    Hayashi T; Hutin YJ; Bulterys M; Altaf A; Allegranzi B
    BMC Health Serv Res; 2019 Aug; 19(1):600. PubMed ID: 31455315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Injections--how safe.
    Sharma S
    J Indian Med Assoc; 2005 Apr; 103(4):210-1. PubMed ID: 16173426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Avoiding reused instruments for immunizations exposes unsolved problems.
    Gisselquist D
    Int J Occup Environ Health; 2009; 15(1):107-8. PubMed ID: 19267129
    [No Abstract]   [Full Text] [Related]  

  • 48. Population risk of syringe reuse: estimating the probability of transmitting bloodborne disease.
    Sikora C; Chandran AU; Joffe AM; Johnson D; Johnson M
    Infect Control Hosp Epidemiol; 2010 Jul; 31(7):748-54. PubMed ID: 20509761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perinephric abscess from insulin syringe reuse.
    Paily R
    Am J Med Sci; 2004 Jan; 327(1):47-8. PubMed ID: 14722397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses.
    Kermode M
    Health Promot Int; 2004 Mar; 19(1):95-103. PubMed ID: 14976177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Injection safety: knowledge and practice among health workers.
    Ernest SK
    West Afr J Med; 2002; 21(1):70-3. PubMed ID: 12081351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. One needle, one syringe, only one time? A survey of physician and nurse knowledge, attitudes, and practices around injection safety.
    Kossover-Smith RA; Coutts K; Hatfield KM; Cochran R; Akselrod H; Schaefer MK; Perz JF; Bruss K
    Am J Infect Control; 2017 Sep; 45(9):1018-1023. PubMed ID: 28625701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety of immunization injections in Africa: not simply a problem of logistics.
    Dicko M; Oni AQ; Ganivet S; Kone S; Pierre L; Jacquet B
    Bull World Health Organ; 2000; 78(2):163-9. PubMed ID: 10743280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Issues and options for the safe destruction and disposal of used injection materials.
    Tamplin SA; Davidson D; Powis B; O'Leary Z
    Waste Manag; 2005; 25(6):655-65. PubMed ID: 15993350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reuse of disposable syringe-needle sets in the diabetic patient--fact or fiction?
    Fawbush MW
    Fla Nurse; 1984 Oct; 32(10):15. PubMed ID: 6391966
    [No Abstract]   [Full Text] [Related]  

  • 56. Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States metropolitan areas.
    Gleghorn AA; Wright-De Agüero L; Flynn C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S30-6. PubMed ID: 9663621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Syringes must be prioritized globally to ensure equitable access to COVID-19 and other essential vaccines and to sustain safe injection practices.
    Fritz J; Griffin E; Hammack R; Herrick T; Jarrahian C
    Hum Vaccin Immunother; 2022 Dec; 18(7):2077580. PubMed ID: 35648471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A global health partnership's use of time-limited support to catalyze health practice change: the case of GAVI's Injection Safety Support.
    Levin A; Fang A; Hansen PM; Pyle D; Dia O; Schwalbe N
    PLoS One; 2010 Sep; 5(9):e12986. PubMed ID: 20885995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.
    Cotten-Oldenburg NU; Carr P; DeBoer JM; Collison EK; Novotny G
    J Acquir Immune Defic Syndr; 2001 Jun; 27(2):183-92. PubMed ID: 11404541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.